With “FDA Revitalization” Bills On Hold, Agency Taps Reserve For Salaries
This article was originally published in The Tan Sheet
Executive Summary
FDA is using reserve funding to pay salaries normally funded by drug industry user fees as Congress works to finalize "FDA Revitalization" legislation, Commissioner Andrew von Eschenbach said Aug. 2